These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Amisulpride versus olanzapine in the treatment of schizophrenia in Indian patients: randomized controlled trial. Bhowmick S, Hazra A, Ghosh M. Aust N Z J Psychiatry; 2010 Mar; 44(3):237-42. PubMed ID: 20050717 [Abstract] [Full Text] [Related]
4. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO]. István S, Agoston T, Tamás T, Zoltán J. Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029 [Abstract] [Full Text] [Related]
7. A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients. Riedel M, Eich FX, Möller HJ. Eur Psychiatry; 2009 Apr; 24(3):149-53. PubMed ID: 19070995 [Abstract] [Full Text] [Related]
18. A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia. Mortimer A, Martin S, Lôo H, Peuskens J, SOLIANOL Sudy Group. Int Clin Psychopharmacol; 2004 Mar; 19(2):63-9. PubMed ID: 15076013 [Abstract] [Full Text] [Related]
20. Minimum effective doses of haloperidol for the treatment of first psychotic episode: a comparative study with risperidone and olanzapine. Apiquian R, Fresán A, Herrera K, Ulloa RE, Lóyzaga C, de la Fuente-Sandoval C, Gutiérrez D, Nicolini H. Int J Neuropsychopharmacol; 2003 Dec; 6(4):403-8. PubMed ID: 14604455 [Abstract] [Full Text] [Related] Page: [Next] [New Search]